1. Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief 2020; 360:1–8.
2. Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity N Engl J Med 2019;381:2440–2450.
3. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin 2021;71:7–33.
4. Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 2019;92: 121–135.
5. Cohen SS, Palmieri RT, Nyante SJ, et al. Obesity and screening for breast, cervical, and colorectal cancer in women: a review. Cancer 2008;112: 1892–1904.
6. Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med 2004;19:332–338.
7. Munsell MF, Sprague BL, Berry DA, et al. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev 2014;36:114–136.
8. Liu PH, Wu K, Ng K, et al. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol 2019;5:37–44.
9. Ligibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol 2014;32: 3568–3574.
10. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:31–54.
13. Ferrante JM, Chen PH, Crabtree BF, et al. Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 2007;32:525–531.
14. Maruthur NM, Bolen S, Brancati FL, et al. Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med 2009;24:665–677.
15. Beaber EF, Sprague BL, Tosteson ANA, et al. Multilevel predictors of continued adherence to breast cancer screening among women ages 50– 74 years in a screening population. J Womens Health (Larchmt) 2019;28: 1051–1059.
16. Carlos RC, Fendrick AM, Ellis J, et al. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? J Am Coll Radiol 2004;1:769–776.
17. Carlos RC, Fendrick AM, Patterson SK, et al. Associations in breast and colon cancer screening behavior in women. Acad Radiol 2005;12:451–458.
18. Ferrante JM, Ohman-Strickland P, Hudson SV, et al. Colorectal cancer screening among obese versus non-obese patients in primary care practices. Cancer Detect Prev 2006;30:459–465.
19. US Preventive Services Task Force, ; Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement JAMA 2016;315:2564–2575.
20. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2009;151:716–26, W-236.
21. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879–1886. .
22. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541–1548.
23. Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999; 91:1829–1846.
24. Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358–366.
25. Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007;99:1782–1792.
26. Matsuno RK, Costantino JP, Ziegler RG, et al. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst 2011;103:951–961.
27. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373.
28. Susan G. Komen. Breast self-awareness messages. https://www.komen.org/ breast-cancer/screening/self-awareness. Accessed January 2023.
31. Khaliq W, Aamar A, Wright SM. Predictors of non-adherence to breast cancer screening among hospitalized women. PLoS ONE 2015;10:e0145492.
32. Siraj NS, Kauffman R, Khaliq W. Predictors of nonadherence to colorectal cancer screening among hospitalized women. South Med J 2022;115:687–692.
33. Khaliq W, Visvanathan K, Landis R, et al. Breast cancer screening preferences among hospitalized women. J Womens Health (Larchmt) 2013;22:637–642.
34. Graham H, Kauffman R, Khaliq W. Colorectal cancer screening prevalence, perceived barriers, and preference for screening colonoscopy among hospitalized women. Turk J Gastroenterol 2022;33:901–908.
35. Eichholzer M, Richard A, Rohrmann S, et al. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey. Eur J Cancer Prev 2016;25:130–136.
36. Seibert RG, Hanchate AD, Berz JP, et al. National disparities in colorectal cancer screening among obese adults. Am J Prev Med 2017;53:e41–e49.
37. Miles RC, Lehman CD, Mercaldo SF, et al. Obesity and breast cancer screening: cross-sectional survey results from the behavioral risk factor surveillance system. Cancer 2019;125:4158–4163.
38. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med 2005;20:989–995.
39. Potter MB, Vu JD, Croughan-Minihane M. Weight management: what patients want from their primary care physicians. J Fam Pract 2001;50: 513–518.
40. Howe EE, Wright SM, Landis R, et al. Addressing obesity in the hospitalized patient: a needs assessment. South Med J 2010;103:500–504.
41. Srivastava G, Johnson ED, Earle RL, et al. Underdocumentation of obesity by medical residents highlights challenges to effective obesity care. Obesity (Silver Spring) 2018;26:1277–1284.
42. Hossain MA, Amin A, Paul A, et al. Recognizing obesity in adult hospitalized patients: a retrospective cohort study assessing rates of documentation and prevalence of obesity. J Clin Med 2018;7:203.
43. Salazar-Sepúlveda LL, Villarreal-Pérez JZ. Impact of diagnosis of overweight and obesity on weight management among hospitalized patients. Obes Res Clin Pract 2019;13:164–167.
44. Bordowitz R, Morland K, Reich D. The use of an electronic medical record to improve documentation and treatment of obesity. Fam Med 2007;39: 274–279.
45. Wachsberg KN, Feinglass J, Williams MV, et al. Willingness for weight loss intervention among overweight and obese inpatients. South Med J 2011;104: 397–400.
46. Harris CM, Rios R, Landis R, et al. Receptivity to weight management interventions among hospitalized obese patients: an untapped opportunity. South Med J 2013;106:337–342.
47. Khaliq W, Landis R, Wright SM. Improving breast cancer screening adherence among hospitalized women. J Womens Health (Larchmt) 2017; 26:1094–1098.
48. Wools A, Dapper EA, de Leeuw JRJ. Colorectal cancer screening participation: a systematic review. Eur J Public Health 2016;26:158–168.
49. Muthukrishnan M, Arnold LD, James AS. Patients’ self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep 2019;15:100896.
50. Boling W, Laufman L, Lynch GR, et al. Increasing mammography screening through inpatient education. J Cancer Educ 2005;20:247–250.